The U.S. retail pharmacy segment had third quarter sales of $27.9 billion, an increase of 4.4% from the year-ago quarter, while comparable sales increased 7% from the year-ago quarter.
Generic Spiriva HandiHaler is indicated for the long-term, once-daily, maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease.